ARCN1 suppresses innate immune responses against respiratory syncytial virus by promoting STUB1-mediated IKKε degradation
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013751 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Jiamin Cai und 19 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth Affiliated Hospital, Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, People's Republic of …. Hauptthemen laut MEDLINE: Immunity, Innate, Ubiquitin-Protein Ligases, Respiratory Syncytial Virus Infections, I-kappa B Kinase. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Social Development Project of Jiangsu Province, Laboratory of Respiratory Disease of Suzhou.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV), a filamentous, enveloped, negative-sense, single-stranded RNA virus, is a common cause of respiratory infections in pediatric and elderly populations, often leading to severe inflammation and lung damage. To date, there is no effective treatment for RSV infection. Therefore, elucidating the antiviral mechanism in RSV infection is critical for identifying potential effective therapeutic targets. Type I interferons (IFN-Is), especially IFN-β, play a key role in the immediate immune response against viral infection by inhibiting viral load and spread. Current studies have shown that ARCN1 (archain 1), the δ subunit of the coat protein complex I complex, is involved in intra-Golgi trafficking and protein transport from the Golgi apparatus back to the endoplasmic reticulum. In this study, we demonstrate that ARCN1 suppresses the anti-RSV innate immune response by promoting E3 ubiquitin ligase STUB1-mediated K48-linked polyubiquitination and subsequent proteasomal degradation of IKKε. Mechanistically, ARCN1 recognizes and binds to the δL motif of STUB1 via its flexible MHD domain while interacting with IKKε. This finding provides a theoretical basis for the development of new antiviral treatment strategies targeting ARCN1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Fourth Affiliated Hospital, Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, People's Republic of China.
- Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.
- Department of Clinical Laboratory, Soochow University Affiliated No 1 People's Hospital: First Affiliated Hospital of Soochow University, Suzhou, China.
ORCID-Profile: Jinping Zhang
Förderung
- National Natural Science Foundation of China
- Social Development Project of Jiangsu Province
- Laboratory of Respiratory Disease of Suzhou
- Key Laboratory for Diagnosis and Treatment of Immune Diseases in Children
- Clinician Scientist Project of Suzhou Medical College
- Jiangsu Key Laboratory of Infection and Immunity
- Institutes of Biology and Medical Sciences of Soochow University
- Key Laboratory of Respiratory Disease of Suzhou
Zitieren
APA
Cai, J., Ye, Y., Chen, Z., Xu, F., Li, X., Wu, M., Zhou, J., Shao, Y., Zhu, P., Zhao, J., Hu, J., Wang, Y., Li, C., Tian, X., Huang, B., Xia, T., Wang, W., Hao, C., Yang, Y., & Zhang, J. (2025). ARCN1 suppresses innate immune responses against respiratory syncytial virus by promoting STUB1-mediated IKKε degradation. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013751
Vancouver
Cai J, Ye Y, Chen Z, Xu F, Li X, Wu M, et al. ARCN1 suppresses innate immune responses against respiratory syncytial virus by promoting STUB1-mediated IKKε degradation. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013751
BibTeX
@article{Cai2025,
author = {Cai, Jiamin and Ye, Yunfei and Chen, Zhengrong and Xu, Fei and Li, Xiaoping and Wu, Mengyun and Zhou, Ji and Shao, Yu and Zhu, Peijie and Zhao, Jing and Hu, Jingjing and Wang, Yufeng and Li, Cancheng and Tian, Xiaoyu and Huang, Beibei and Xia, Tian and Wang, Wenjun and Hao, Chuangli and Yang, Yi and Zhang, Jinping},
title = {ARCN1 suppresses innate immune responses against respiratory syncytial virus by promoting STUB1-mediated IKKε degradation},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013751}
}
EUVIMED